Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.204
+0.001 (0.69%)
At close: Apr 28, 2026, 4:00 PM EDT
0.204
+0.000 (0.05%)
After-hours: Apr 28, 2026, 7:49 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $9.15 million as of April 28, 2026. Its market cap has decreased by -88.58% in one year.
Market Cap
9.15M
Enterprise Value
10.13M
1-Year Change
-88.58%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $9.15M, a decrease of -97.36%. That is a compound annual growth rate of -52.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 9.09M | -44.95% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 9.92M |
| GT Biopharma | 9.86M |
| Genprex | 9.39M |
| Bolt Biotherapeutics | 9.28M |
| CalciMedica | 9.20M |
| NuCana | 8.57M |
| Creative Medical Technology Holdings | 8.50M |
| Silo Pharma | 8.13M |